• MELVIN NOVA GUNAWANTO BARUS Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
  • SYAFRUDDINILYAS Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Sumatera Utara, Indonesia
  • MAKMUR SITEPU Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
  • ADANG BACHTIAR Department of Health Policy and Development, Faculty of Public Health, Universitas Indonesia, Jakarta, Indonesia



Andaliman, (Zanthoxylumacantophodium, TNF-a, IL-6, Preeclampsia


Objective: This study is the first study to test the effect of andaliman on preeclampsia. This study aims to discover whether andaliman fruit extract (Zanthoxylum acanthopodium DC) affects the level of TNF α and IL-6 in preeclamptic LPS Induces mice

Methods: This study uses analytical research with quasi-experimental research design in laboratory rats (Micetus Norvegicus) pregnant females given andaliman extract (zantoxylumacantophodium) at doses of 100 mg and 200 mg per day. The study design allowed the researchers to measure the effect of treatment (intervention) in the experimental group by way of comparing the experimental group and control group. This design allows the researcher to determine the extent or extent of the change. The treatment of all samples was carried out simultaneously and during the treatment, it was observed using the type of Postest Only Control Group.

Results: Andaliman has been shown to reduce TNF-α levels in preeclampsia mice. The mean TNF-α in the K-, P1, P2 and K+ groups was 84.4; 90.1; 95.1; 109.7 (P<0.001). Andaliman has been shown to reduce IL-6 levels in preeclampsia rats. The mean IL-6 in the K-, P1, P2 and K+groups was 16.7; 67.5; 18.8; 21.1 (P<0.001).

Conclusion: This study proves that there are anti-inflammatory effects possessed by the extract of Andaliman (Zanthoxylum acanthopodium), thus showing a decrease in proinflammatory cytokine levels, namely TNF-α, IL6. This study also has a good clinical outcome after administering Andaliman extract (Zanthoxylum acanthopodium), where there are improvements in blood pressure, cystole-diastole, MAP and decreased urinary protein in research subjects with preeclampsia.


Download data is not yet available.


1. Oakes MC, Hameed AB. Preeclampsia: an overview. Med J Obstetric Gynecol 2016;4:1082.
2. Palei AC, Granger JP, Tanus Santos JE. Matrix metalloproteinases as drug targets in preeclampsia. Curr Drug Targets 2013;14:325-34.
3. Park CH, Oh PS, Lim KT. Inhibitory effect of phytoglycoprotein (115 kDa) on the expression of TNF-? and interleukin-1? via inhibition of MAP kinase in primary cultured mouse thymocytes. Biosci Biotechnol Biochem 2009;73:2196-202.
4. Patigaroo FA, Siddiqui AH, Gulati R, Mohsin Z. Tumor necrosis factor alpha in preeclampsia. Int J Basic Appl Physiol 2014;2:1.
5. Patino LO, Prieto RJ, Cuca SL. Zanthoxylum genus as potential source of bioactive compounds. Bioactive Compounds in Phytomedicine InTech; 2012. Doi:10.5772/26037
6. Pennington KA, Schlitt JM, Jackson DL, Schulz LC, Schust DJ. Preeclampsia: multiple approachs for a multifactorial disease. Disease Models Mechanisms 2012;5:9-18.
7. Pinheiro MB, Gomes KB, Guimaraes GG, Freitas LG, Dusse LM. Severe preeclampsia: association of genes polymorphismsand maternal cytokines production in Brazilianpopulation. Elsevier 2015;62:165-73.
8. Plaks V, Rinkenberger J, Dai J, Flannery M, Sund M, Kanasaki K, et al. Matrix metalloproteinase-9 deficiency phenocopies features of preeclampsia and intrauterine growth restriction. PNAS 2013;110:11109-14.
9. Podjarny E. Animal models of preeclampsia. Semin Nephrol NIH Public Access; 2004. p. 596–606.
10. POGI. Prediksi dan pencegahan preeklampsia. Dalam: Diagnosis dan tatalaksana pre-eklampsia. Jakarta: POGI; 2016. p. 11-20.
11. Prieto JA, Patiño OJ, Delgado WA, Moreno JP, Cuca LE. Chemical composition, insecticidal, and antifungal activities of fruit essential oils of three colombian zanthoxylum species. Chilean J Agric Res 2011;71:73.
12. Sosa SE, Pliego AF, Nunez AS, Bastidas DM, Ortega FV, Clavellina VZ, et al. New insights into the role of matrix metalloproteinases in preeclampsia. Int J Mol Sci 2017;18:1448.
13. Sovio U, Gaccioli F, Cook, Hund M, Jones D, Smith G. Prediction of preeclampsia using the soluble fms-like tyrosine kinase 1 to placental growth factor ratio. Hypertension 2017;69:731-8.
14. Spradley FT, Palei AC, Granger JP. Immune mechanisms linking obesity and preeclampsia. Biomolecules 2015;5:3142-76.
15. Sulistyowati S. Early and late-onset preeclampsia: What Did Really Matter. J Gynecol Women’s Health 2017;5:1-3.
16. Suryanto E. Sastrohamidjojo Kadar, Raharjo S. Antiradical activity of andaliman (Zanthoxylumachanthopodium DC) fruit extract. Indonesian Food Nutr Progress 2004;11:15-9.
17. Suzuki Kadar, Ohkuchi A, Shirasuna K, Takahashi Kadar, Usui R, Matsubara S, et al. Animal models of preeclampsia: insight into possible biomarker candidates for predicting preeclampsia. Med J Obstetrics Gynecol 2014;2:1031.
18. Tal R, Shaish A, Barshack I, Polak Charcon S, Afek A, Volkov A, et al. Effects of hypoxia-inducible factor-1? overexpression in pregnantmice: possible implications for preeclampsia and intrauterine growth restriction. Am J Pathol 2010;177:2950-62.



How to Cite

BARUS, M. N. G., SYAFRUDDINILYAS, M. SITEPU, and A. BACHTIAR. “ANDALIMAN FRUIT EXTRACT (ZANTHOXYLUM ACANTOPHODIUM) AND IT’S EFFECT ON PREECLAMPSIA AS ANTI-INFLAMMATORY”. International Journal of Current Pharmaceutical Research, vol. 12, no. 2, Mar. 2020, pp. 75-77, doi:10.22159/ijcpr.2020v12i2.37494.



Original Article(s)